logo
Plus   Neg
Share
Email

Croda To Buy French Fine Fragrance Business Parfex For €45 Mln - Quick Facts

Croda International Plc (CRDA.L) announced Wednesday that its fragrances and flavours subsidiary, Iberchem, has agreed to acquire Parfex S.A., a French fine fragrance business, for a total enterprise value of 45 million euros.

The transaction is subject to customary pre closing conditions and is expected to close by the end of the second quarter of 2021.

Parfex, established in 1985, creates fragrances principally for premium personal care and fine perfumery markets. The company, which employs 75 people, generated 3.6 million euros EBITDA in 2020, and now sells its fragrances in more than 50 countries worldwide.

Parfex is 82% owned by its founders with the remaining free float of shares listed on the Euronext Access market.

Under the deal, Croda has agreed to acquire 93% of Parfex's outstanding shares, comprising the founding shareholders and certain minority investors. Croda expects to acquire 100% of the total outstanding share capital, subject to a potential tender offer and subsequent de-listing.

Steve Foots, Croda Chief Executive Officer, said, "We believe that transitioning to more natural raw materials is a potential differentiator in the fragrance market. Parfex will play an important role in Iberchem's plans to increase its sustainable fragrance offerings and further enhances our position in the creation of higher-value fine fragrances."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Performance Food Group Co. announced Tuesday its agreement to acquire Core-Mark Holding Co., Inc., a wholesale distributor to the convenience retail industry, in around $2.5 billion stock and cash transaction, including net debt. In pre-markey activity on Nasdaq, Core-Mark shares were gaining around 9 percent to trade at $45.86. Retail giant Walmart Inc. reported Tuesday a profit for the first quarter of fiscal 2022 that declined 31.6 percent from last year, hurt by net losses on equity investments, However, adjusted earnings per share and quarterly revenues topped analysts' expectations. The retailer also raised its guidance for the second quarter and for the full-year 2022. European Medicines Agency or EMA announced that Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech, can have more flexible storage conditions, including up to one month in a normal fridge. The proposed change in the approved storage conditions, recommended by EMA's human medicines committee or CHMP, will help in easy handling of the vaccine in vaccination centres across the EU.
Follow RTT